CSOP Bitcoin Futures ETF
03066
Samsung Bitcoin Futures Active ETF
03135
Harvest Bitcoin Spot ETF
03439
Bosera HashKey Bitcoin ETF
03008
ChinaAMC Bitcoin ETF
03042
HK Stock MarketDetailed Quotes
01515 CR MEDICAL
- 4.020
- +0.030+0.75%
Not Open Dec 11 16:08 CST
5.21BMarket Cap16.21P/E (TTM)
4.060High3.990Low3.82MVolume3.990Open3.990Pre Close15.35MTurnover0.30%Turnover Ratio18.36P/E (Static)1.30BShares5.01052wk High0.77P/B5.21BFloat Cap3.00552wk Low0.12Dividend TTM1.30BShs Float16.271Historical High0.066Dividend LFY1.75%Amplitude2.584Historical Low4.015Avg Price500Lot Size3.01%Div YieldTTM1.64%Div Yield LFY
CR MEDICAL Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 16.55%492.92M | ---- | 56.37%422.94M | ---- | -35.32%270.48M | ---- | -22.74%418.19M | ---- | -8.09%541.3M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 8.59%-85.33M | ---- | -20.54%-93.35M | ---- | 3.11%-77.45M | ---- | -23.00%-79.93M | ---- | 2.17%-64.98M |
| Dividend (income)- adjustment | ---- | -19.14%-3.87M | ---- | -16.24%-3.25M | ---- | -6.76%-2.8M | ---- | -398.67%-2.62M | ---- | 77.36%-525K |
| Attributable subsidiary (profit) loss | ---- | -3.08%-90.78M | ---- | -5.40%-88.07M | ---- | -138.94%-83.55M | ---- | -652.65%-34.97M | ---- | -116.39%-4.65M |
| Impairment and provisions: | ---- | 252.24%481.37M | ---- | -61.54%136.66M | ---- | 1,410.26%355.29M | ---- | 1,391.76%23.53M | ---- | 2,326.15%1.58M |
| -Impairment of property, plant and equipment (reversal) | ---- | 41,231.18%210.79M | ---- | --510K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 1,036.84%216K | ---- | --19K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | 30.18%141.02M | ---- | --108.32M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 365.18%129.35M | ---- | -92.17%27.81M | ---- | 1,410.26%355.29M | ---- | 1,391.76%23.53M | ---- | 2,326.15%1.58M |
| Revaluation surplus: | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- | 86.35%25.14M | ---- | 370.25%13.49M |
| -Other fair value changes | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- | 86.35%25.14M | ---- | 370.25%13.49M |
| Asset sale loss (gain): | ---- | 144.43%2.39M | ---- | ---5.37M | ---- | ---- | ---- | ---- | ---- | 200.00%795K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---5.68M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 671.84%2.39M | ---- | --309K | ---- | ---- | ---- | ---- | ---- | -49.04%795K |
| Depreciation and amortization: | ---- | 28.67%595.58M | ---- | 153.10%462.87M | ---- | 61.29%182.88M | ---- | 78.15%113.38M | ---- | -12.80%63.64M |
| -Amortization of intangible assets | ---- | -2.60%6.52M | ---- | 0.01%6.69M | ---- | -15.25%6.69M | ---- | -57.88%7.9M | ---- | -10.82%18.75M |
| -Other depreciation and amortization | ---- | 35.07%-15.28M | ---- | ---23.53M | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial expense | ---- | 85.30%131.84M | ---- | 298.95%71.15M | ---- | 2.55%17.83M | ---- | 2.65%17.39M | ---- | 120.00%16.94M |
| Exchange Loss (gain) | ---- | -51.10%77.69M | ---- | 692.87%158.88M | ---- | 39.53%-26.8M | ---- | -464.48%-44.31M | ---- | -28.33%12.16M |
| Special items | ---- | ---- | ---- | -81.02%1.92M | ---- | 454.24%10.11M | ---- | -121.62%-2.85M | ---- | 348.42%13.2M |
| Operating profit before the change of operating capital | ---- | 52.85%1.62B | ---- | 57.22%1.06B | ---- | 55.54%673.41M | ---- | -26.99%432.94M | ---- | -1.94%592.95M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 476.00%65.18M | ---- | -8,316.11%-17.34M | ---- | 100.91%211K | ---- | -247.77%-23.29M | ---- | 142.28%15.76M |
| Accounts receivable (increase)decrease | ---- | -226.34%-120.28M | ---- | -30.77%95.2M | ---- | 48.30%137.52M | ---- | 174.59%92.73M | ---- | -5.34%-124.32M |
| Accounts payable increase (decrease) | ---- | -26.41%-219.28M | ---- | -60.52%-173.46M | ---- | -144.84%-108.06M | ---- | 517.85%240.97M | ---- | 2,368.48%39M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | 17,023.27%132.34M | ---- | -173.22%-782K | ---- | 300.75%1.07M |
| Special items for working capital changes | ---- | -599.06%-38.94M | ---- | 160.75%7.8M | ---- | -25.69%-12.84M | ---- | -284.71%-10.22M | ---- | -106.52%-2.66M |
| Cash from business operations | ---- | 34.40%1.31B | ---- | 18.04%970.97M | ---- | 12.32%822.58M | ---- | 40.35%732.35M | ---- | 6.24%521.81M |
| Other taxs | ---- | -13.60%-163.4M | ---- | -5.77%-143.84M | ---- | -38.38%-135.99M | ---- | 40.03%-98.27M | ---- | -0.73%-163.88M |
| Interest received - operating | ---- | 46.78%53.51M | ---- | 52.90%36.46M | ---- | 148.04%23.84M | ---- | 18.33%9.61M | ---- | 42.78%8.12M |
| Special items of business | -6.05%507.76M | ---- | 459.47%540.44M | ---- | -24.18%96.6M | ---- | -43.40%127.41M | ---- | 3,067.93%225.11M | ---- |
| Net cash from operations | -6.05%507.76M | 38.39%1.2B | 459.47%540.44M | 21.56%863.59M | -24.18%96.6M | 10.37%710.43M | -43.40%127.41M | 75.85%643.69M | 3,067.93%225.11M | 9.55%366.05M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -7.28%3.59M | 1,990.00%92.75M | 19.14%3.87M | 58.78%4.44M | 16.24%3.25M | 6.76%2.8M | 6.76%2.8M | 398.67%2.62M | 398.67%2.62M | -77.36%525K |
| Loan receivable (increase) decrease | 45.94%3.49M | -40.84%7.39M | -35.23%2.39M | 11.63%12.49M | 54.46%3.69M | -41.87%11.19M | -47.57%2.39M | 113.32%19.25M | 214.00%4.55M | -42.31%9.02M |
| Decrease in deposits (increase) | -386.13%-9.49M | -838.55%-25.41M | 369.59%3.32M | -73.25%3.44M | -107.06%-1.23M | 173.85%12.86M | 335.11%17.42M | ---17.42M | 120.39%4M | ---- |
| Sale of fixed assets | -33.99%5.23M | 797.10%54.98M | 104.70%7.93M | 192.41%6.13M | 86.60%3.87M | -71.67%2.1M | 177.78%2.08M | 99.43%7.4M | 105.79%747K | 29.86%3.71M |
| Purchase of fixed assets | -28.24%-248.39M | -4.38%-486.68M | -78.22%-193.69M | -134.98%-466.28M | -46.22%-108.68M | 5.30%-198.43M | -328.43%-74.33M | -476.23%-209.55M | -85.00%-17.35M | 36.87%-36.37M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | -260.30%-28.82M | ---- | ---8M | ---- | ---- |
| Sale of subsidiaries | ---- | -75,360,740.00%-3.77B | ---- | --5K | --50K | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | 126.70%173.92M | 120.25%173.92M | -656.53%-651.28M | -832.63%-858.76M | 39,108.67%117.03M | --117.22M | 88.70%-300K |
| Recovery of cash from investments | -97.90%55.6M | -25.58%3.57B | 28.19%2.65B | 12.05%4.79B | 34.19%2.07B | -38.23%4.28B | -59.44%1.54B | 18.48%6.92B | 39.22%3.8B | 16.46%5.84B |
| Cash on investment | 97.82%-55M | 38.76%-2.68B | -18.19%-2.53B | 18.35%-4.38B | 25.15%-2.14B | 20.78%-5.37B | 39.74%-2.86B | -19.13%-6.77B | -74.20%-4.74B | -17.25%-5.69B |
| Other items in the investment business | -103.64%-16.31M | 197.15%620.19M | --448.04M | -18,847.90%-638.37M | ---- | --3.41M | 150.49%4.09M | ---- | -134.25%-8.09M | 7,973.00%23.62M |
| Net cash from investment operations | -165.53%-261.29M | -430.77%-2.62B | 5,417.64%398.71M | 74.48%-494.02M | 100.33%7.23M | -3,307.23%-1.94B | -166.31%-2.22B | -61.61%60.37M | -10,833.53%-832.6M | -55.76%157.24M |
| Net cash before financing | -73.75%246.48M | -486.12%-1.43B | 804.55%939.14M | 130.15%369.57M | 104.97%103.82M | -274.08%-1.23B | -244.03%-2.09B | 34.54%704.05M | -4,187.24%-607.49M | -24.11%523.29M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -41.22%1.14B | -35.52%5.55B | -55.85%1.94B | 41.85%8.61B | 47.96%4.39B | 1,233.95%6.07B | 2,139.09%2.97B | 386.18%455.24M | 1,421.75%132.59M | -69.16%93.64M |
| Refund | 32.41%-1.28B | 33.03%-5.77B | 56.98%-1.9B | -69.39%-8.62B | -122.59%-4.41B | -1,513.32%-5.09B | ---1.98B | -1,738.65%-315.44M | ---- | -40,747.62%-17.16M |
| Interest paid - financing | 43.32%-30.88M | -106.16%-116.27M | -302.93%-54.49M | -185.20%-56.4M | -65.06%-13.52M | -39.06%-19.77M | 11.78%-8.19M | 15.52%-14.22M | -86.82%-9.29M | -147.54%-16.83M |
| Dividends paid - financing | ---- | 57.33%-55.53M | -2,085.82%-11.87M | -30.20%-130.14M | 99.40%-543K | 20.49%-99.96M | 21.34%-91.08M | 11.72%-125.73M | -958.89%-115.78M | -9.83%-142.42M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | -65.46%544K | ---- | 1.29%1.58M | -24.03%980K | -27.30%1.56M |
| Other items of the financing business | ---- | ---- | ---- | ---474K | ---- | ---- | -345.42%-724K | -100.30%-127K | -99.27%295K | 120.09%42.99M |
| Net cash from financing operations | -426.70%-192.27M | -95.40%-437.08M | 17.57%-36.5M | -126.44%-223.69M | -105.03%-44.29M | 11,559.71%845.96M | 11,387.69%879.84M | 81.98%-7.38M | -55.44%7.66M | 8.39%-40.97M |
| Effect of rate | -73.78%183K | -94.84%141K | -60.00%698K | 16.84%2.73M | 139.91%1.75M | 253.85%2.34M | -461.02%-4.37M | -441.28%-1.52M | 256.87%1.21M | -112.37%-281K |
| Net Cash | -93.99%54.21M | -1,377.84%-1.86B | 1,416.10%902.64M | 138.42%145.88M | 104.92%59.54M | -154.50%-379.66M | -101.74%-1.21B | 44.44%696.67M | -1,971.48%-599.83M | -25.20%482.33M |
| Begining period cash | -60.13%1.24B | 5.04%3.1B | 5.04%3.1B | 9.26%2.95B | 9.26%2.95B | 34.65%2.7B | 34.65%2.7B | 31.63%2.01B | 31.63%2.01B | 73.78%1.52B |
| Cash at the end | -67.76%1.29B | -60.13%1.24B | 32.88%4B | 33.39%3.1B | 102.61%3.01B | -13.97%2.32B | 5.63%1.49B | 34.65%2.7B | -9.51%1.41B | 31.63%2.01B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending HK Stocks
HK Crypto ETF HK Crypto ETF
An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.
